The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
US FDA issues guidance on modernizing statistical methods for clinical trials: Maryland Wednesday, January 14, 2026, 09:00 Hrs [IST] The US Food and Drug Administration today publ ...
Through tumor profiling and statistical analysis, precision oncology uses genomic and other biomarkers to drive discovery, drug development, and clinical care for patients with cancer. It intends to ...
Abstract: Assumptions play a pivotal role in the selection and efficacy of statistical models, as unmet assumptions can lead to flawed conclusions and impact decision-making. In both traditional ...
An ad hoc panel of nationally renowned experts in social science research, computing technology, statistical methods, privacy, and use of alternative data sources in the United States and abroad will ...
Precision oncology exploits genomic, immunologic, and other biomarkers to drive discovery, drug development, and clinical care for patients with cancer. Precision oncology helps devise individualized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback